← Open Payments lookup

CHERIE SIMPSON: Open Payments

NPI 1720030307 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,125 in 34 payments from 12 companies in 2025. Trend: 2023 $1,181 · 2024 $1,069 · 2025 $1,125

Food & beverage: $1,125
CompanyPaymentsAmount
Axsome Therapeutics, Inc.6$239
Lilly USA, LLC5$149
Biogen, Inc.2$136
Janssen Pharmaceuticals, Inc2$129
Lundbeck LLC4$98
ACADIA Pharmaceuticals Inc4$88
Eisai Inc.3$80
ABBVIE INC.2$65
Otsuka America Pharmaceutical, Inc.2$54
Takeda Pharmaceuticals U.S.A., Inc.2$34

Products named: Auvelity, REXULTI, SPRAVATO, KISUNLA, Leqembi, NUPLAZID, VRAYLAR, AMYVID.

Industry payments across TX — which companies pay providers there.